Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Harvard Bioscience 84 OCTOBER HILL RD HOLLISTON MA 01746 USA

www.harvardbioscience.com Employees: 355 P: 508-893-8999 F: 508-429-5732

INDUSTRY GROUPING:

Industrial Scientific

Description:

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

Key Statistics

Overview:

Market Capitalization, $K 26,210
Enterprise Value, $K 59,060
Shares Outstanding, K 44,720
Float, K 35,642
% Float 79.70%
Short Interest, K 585
Short Float 1.31%
Days to Cover 1.98
Short Volume Ratio 0.20
% of Insider Shareholders 20.30%
% of Institutional Shareholders 80.87%

Financials:

Annual Sales, $ 94,140 K
Annual Net Income, $ -12,410 K
Last Quarter Sales, $ 20,590 K
Last Quarter Net Income, $ -1,230 K
EBIT, $ 2,100 K
EBITDA, $ 9,580 K

Growth:

1-Year Return -50.56%
3-Year Return -80.22%
5-Year Return -86.71%
5-Year Revenue Growth -18.97%
5-Year Earnings Growth -158.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/06/25
Next Earnings Date 03/12/26 [BMO]
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 80.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

HBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 5.39
Price/Earnings to Growth N/A
Return-on-Equity % -2.29%
Return-on-Assets % -0.68%
Profit Margin % -13.18%
Debt/Equity 2.41
Price/Sales 0.29
Price/Cash Flow 5.87
Price/Book 1.88
Book Value/Share 0.32
Interest Coverage -2.64
60-Month Beta 1.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar